227 related articles for article (PubMed ID: 33951334)
21. Selective antibacterial activity of a novel lactotransferrin-derived antimicrobial peptide LF-1 against Streptococcus mutans.
Feng Z; Luo J; Lyu X; Chen Y; Zhang L
Arch Oral Biol; 2022 Jul; 139():105446. PubMed ID: 35512618
[TBL] [Abstract][Full Text] [Related]
22. The antibacterial activity of nasturtium officinale extract on common oral pathogenic bacteria.
Tabesh M; Sh ME; Etemadi M; Naddaf F; Heidari F; Alizargar J
Niger J Clin Pract; 2022 Sep; 25(9):1466-1475. PubMed ID: 36149206
[TBL] [Abstract][Full Text] [Related]
23. Effect of histatin-5 and lysozyme on the ability of Streptococcus mutans to form biofilms in in vitro conditions.
Krzyściak W; Jurczak A; Piątkowski J; Kościelniak D; Gregorczyk-Maga I; Kołodziej I; Papież MA; Olczak-Kowalczyk D
Postepy Hig Med Dosw (Online); 2015 Sep; 69():1056-66. PubMed ID: 26400891
[TBL] [Abstract][Full Text] [Related]
24. Targeted antimicrobial therapy against Streptococcus mutans establishes protective non-cariogenic oral biofilms and reduces subsequent infection.
Li LN; Guo LH; Lux R; Eckert R; Yarbrough D; He J; Anderson M; Shi WY
Int J Oral Sci; 2010 Jun; 2(2):66-73. PubMed ID: 20737932
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the use of d-enantiomeric and l-enantiomeric antimicrobial peptides incorporated in a calcium-chelating irrigant against Enterococcus faecalis root canal wall biofilms.
Ye WH; Yeghiasarian L; Cutler CW; Bergeron BE; Sidow S; Xu HHK; Niu LN; Ma JZ; Tay FR
J Dent; 2019 Dec; 91():103231. PubMed ID: 31712128
[TBL] [Abstract][Full Text] [Related]
26. Rational design of peptides with enhanced antimicrobial and anti-biofilm activities against cariogenic bacterium Streptococcus mutans.
Liang D; Li H; Xu X; Liang J; Dai X; Zhao W
Chem Biol Drug Des; 2019 Oct; 94(4):1768-1781. PubMed ID: 31207076
[TBL] [Abstract][Full Text] [Related]
27. [Design, screening and antibacterial activity evaluation of the novel antibacterial peptide KR-1].
He J; Liang D; Liang Y; Zuo S; Zhao W
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jun; 41(6):923-930. PubMed ID: 34238746
[TBL] [Abstract][Full Text] [Related]
28. Biofilm Models for the Evaluation of Dental Treatment.
Eick S
Monogr Oral Sci; 2021; 29():38-52. PubMed ID: 33427232
[TBL] [Abstract][Full Text] [Related]
29. The effects of histatin-derived basic antimicrobial peptides on oral biofilms.
Helmerhorst EJ; Hodgson R; van 't Hof W; Veerman EC; Allison C; Nieuw Amerongen AV
J Dent Res; 1999 Jun; 78(6):1245-50. PubMed ID: 10371248
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial peptide GH12 as root canal irrigant inhibits biofilm and virulence of Enterococcus faecalis.
Li Y; Wang Y; Chen X; Jiang W; Jiang X; Zeng Y; Li X; Feng Z; Luo J; Zhang L
Int Endod J; 2020 Jul; 53(7):948-961. PubMed ID: 32189340
[TBL] [Abstract][Full Text] [Related]
31. Antibacterial effects of N-acetylcysteine against endodontic pathogens.
Moon JH; Choi YS; Lee HW; Heo JS; Chang SW; Lee JY
J Microbiol; 2016 Apr; 54(4):322-9. PubMed ID: 27033208
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial peptides in saliva of children with severe early childhood caries.
Colombo NH; Ribas LF; Pereira JA; Kreling PF; Kressirer CA; Tanner AC; Duque C
Arch Oral Biol; 2016 Sep; 69():40-6. PubMed ID: 27232359
[TBL] [Abstract][Full Text] [Related]
33. The Application of a Recombinant Antimicrobial Peptide of Thrombocidin-1 Expressed in
Forouzanfar F; Mohammadipour HS; Akbari M; Beyraghshamshir R; Tanhaeian A; Karimian E
Protein Pept Lett; 2022; 29(1):102-109. PubMed ID: 34825862
[TBL] [Abstract][Full Text] [Related]
34. Novel Probiotic Mechanisms of the Oral Bacterium
Lee K; Walker AR; Chakraborty B; Kaspar JR; Nascimento MM; Burne RA
Appl Environ Microbiol; 2019 Nov; 85(21):. PubMed ID: 31420345
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial efficacy of alternative compounds for use in oral care toward biofilms from caries-associated bacteria in vitro.
Cieplik F; Kara E; Muehler D; Enax J; Hiller KA; Maisch T; Buchalla W
Microbiologyopen; 2019 Apr; 8(4):e00695. PubMed ID: 30051653
[TBL] [Abstract][Full Text] [Related]
36. Effect of the antimicrobial decapeptide KSL on the growth of oral pathogens and Streptococcus mutans biofilm.
Liu Y; Wang L; Zhou X; Hu S; Zhang S; Wu H
Int J Antimicrob Agents; 2011 Jan; 37(1):33-8. PubMed ID: 20956070
[TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy of a specifically targeted antimicrobial peptide mouth rinse: targeted elimination of Streptococcus mutans and prevention of demineralization.
Sullivan R; Santarpia P; Lavender S; Gittins E; Liu Z; Anderson MH; He J; Shi W; Eckert R
Caries Res; 2011; 45(5):415-28. PubMed ID: 21860239
[TBL] [Abstract][Full Text] [Related]
38. A New Approach Against Some Oral Pathogenic Bacteria Using a Chimeric Antimicrobial Peptide Derived from the Camel Milk; Lactoferrampin - Lactoferricin Chimer.
Mohammadipour HS; Akbari M; Tanhaeian A; Pourgonabadi S; Sekandari S; Karimian E
Curr Drug Discov Technol; 2021; 18(6):e130921187870. PubMed ID: 33183206
[TBL] [Abstract][Full Text] [Related]
39. Caffeic Acid Phenethyl Ester (CAPE) Inhibits Cross-Kingdom Biofilm Formation of Streptococcus mutans and Candida albicans.
Yin W; Zhang Z; Shuai X; Zhou X; Yin D
Microbiol Spectr; 2022 Oct; 10(5):e0157822. PubMed ID: 35980199
[TBL] [Abstract][Full Text] [Related]
40. Reduction of Streptococcus mutans adherence and dental biofilm formation by surface treatment with phosphorylated polyethylene glycol.
Shimotoyodome A; Koudate T; Kobayashi H; Nakamura J; Tokimitsu I; Hase T; Inoue T; Matsukubo T; Takaesu Y
Antimicrob Agents Chemother; 2007 Oct; 51(10):3634-41. PubMed ID: 17646419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
